Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Specific Inhibition of Hepatic Lactate Dehydrogenase Reduces Oxalate Production in Mouse Models of Primary Hyperoxaluria.

Lai C, Pursell N, Gierut J, Saxena U, Zhou W, Dills M, Diwanji R, Dutta C, Koser M, Nazef N, Storr R, Kim B, Martin-Higueras C, Salido E, Wang W, Abrams M, Dudek H, Brown BD.

Mol Ther. 2018 Jun 15. pii: S1525-0016(18)30219-3. doi: 10.1016/j.ymthe.2018.05.016. [Epub ahead of print]

2.

Assessment of IL-31 levels and disease severity in children with atopic dermatitis.

Ozceker D, Bulut M, Ozbay AC, Dilek F, Koser M, Tamay Z, Guler N.

Allergol Immunopathol (Madr). 2018 Jul - Aug;46(4):322-325. doi: 10.1016/j.aller.2017.10.005. Epub 2018 Mar 17.

PMID:
29555105
3.

β-Catenin mRNA Silencing and MEK Inhibition Display Synergistic Efficacy in Preclinical Tumor Models.

Ganesh S, Shui X, Craig KP, Koser ML, Chopda GR, Cyr WA, Lai C, Dudek H, Wang W, Brown BD, Abrams MT.

Mol Cancer Ther. 2018 Feb;17(2):544-553. doi: 10.1158/1535-7163.MCT-17-0605. Epub 2017 Dec 27.

PMID:
29282298
4.

Dose-dependent effects of siRNA-mediated inhibition of SCAP on PCSK9, LDLR, and plasma lipids in mouse and rhesus monkey.

Jensen KK, Tadin-Strapps M, Wang SP, Hubert J, Kan Y, Ma Y, McLaren DG, Previs SF, Herath KB, Mahsut A, Liaw A, Wang S, Stout SJ, Keohan C, Forrest G, Coelho D, Yendluri S, Williams S, Koser M, Bartz S, Akinsanya KO, Pinto S.

J Lipid Res. 2016 Dec;57(12):2150-2162. Epub 2016 Oct 5.

5.

Direct Pharmacological Inhibition of β-Catenin by RNA Interference in Tumors of Diverse Origin.

Ganesh S, Koser ML, Cyr WA, Chopda GR, Tao J, Shui X, Ying B, Chen D, Pandya P, Chipumuro E, Siddiquee Z, Craig K, Lai C, Dudek H, Monga SP, Wang W, Brown BD, Abrams MT.

Mol Cancer Ther. 2016 Sep;15(9):2143-54. doi: 10.1158/1535-7163.MCT-16-0309. Epub 2016 Jul 7.

6.

Inhibition of Glycolate Oxidase With Dicer-substrate siRNA Reduces Calcium Oxalate Deposition in a Mouse Model of Primary Hyperoxaluria Type 1.

Dutta C, Avitahl-Curtis N, Pursell N, Larsson Cohen M, Holmes B, Diwanji R, Zhou W, Apponi L, Koser M, Ying B, Chen D, Shui X, Saxena U, Cyr WA, Shah A, Nazef N, Wang W, Abrams M, Dudek H, Salido E, Brown BD, Lai C.

Mol Ther. 2016 Apr;24(4):770-8. doi: 10.1038/mt.2016.4. Epub 2016 Jan 13.

7.

Mean platelet volume in chronic urticaria and beyond.

Gurdol F, Isıksacan N, Koser M.

Angiology. 2015 Apr;66(4):393-4. doi: 10.1177/0003319714561082. Epub 2014 Dec 3. No abstract available.

PMID:
25477499
8.

Platelet and other hemostatic characteristics in patients with chronic urticaria.

Isiksacan N, Koser M, Cemsitoglu F, Kucuksezer UC, Gurdol F.

Angiology. 2015 Apr;66(4):387-91. doi: 10.1177/0003319714552693. Epub 2014 Sep 30.

PMID:
25274526
9.

A single dose of EGLN1 siRNA yields increased erythropoiesis in nonhuman primates.

Abrams MT, Koser M, Burchard J, Strapps W, Mehmet H, Gindy M, Zaller D, Sepp-Lorenzino L, Stickens D.

Nucleic Acid Ther. 2014 Dec;24(6):405-12. doi: 10.1089/nat.2014.0495.

PMID:
25272050
10.

Interspecies protein substitution to investigate the role of the lyssavirus glycoprotein.

Marston DA, McElhinney LM, Banyard AC, Horton DL, Núñez A, Koser ML, Schnell MJ, Fooks AR.

J Gen Virol. 2013 Feb;94(Pt 2):284-92. doi: 10.1099/vir.0.048827-0. Epub 2012 Oct 24.

11.

Quantitative evaluation of siRNA delivery in vivo.

Pei Y, Hancock PJ, Zhang H, Bartz R, Cherrin C, Innocent N, Pomerantz CJ, Seitzer J, Koser ML, Abrams MT, Xu Y, Kuklin NA, Burke PA, Sachs AB, Sepp-Lorenzino L, Barnett SF.

RNA. 2010 Dec;16(12):2553-63. doi: 10.1261/rna.2255810. Epub 2010 Oct 12.

12.

Effect of biological matrix and sample preparation on qPCR quantitation of siRNA drugs in animal tissues.

Seitzer J, Zhang H, Koser M, Pei Y, Abrams M.

J Pharmacol Toxicol Methods. 2011 Mar-Apr;63(2):168-73. doi: 10.1016/j.vascn.2010.09.005. Epub 2010 Sep 25.

PMID:
20884364
13.

Evaluation of efficacy, biodistribution, and inflammation for a potent siRNA nanoparticle: effect of dexamethasone co-treatment.

Abrams MT, Koser ML, Seitzer J, Williams SC, DiPietro MA, Wang W, Shaw AW, Mao X, Jadhav V, Davide JP, Burke PA, Sachs AB, Stirdivant SM, Sepp-Lorenzino L.

Mol Ther. 2010 Jan;18(1):171-80. doi: 10.1038/mt.2009.208. Epub 2009 Sep 8.

14.

Highly attenuated rabies virus-based vaccine vectors expressing simian-human immunodeficiency virus89.6P Env and simian immunodeficiency virusmac239 Gag are safe in rhesus macaques and protect from an AIDS-like disease.

McKenna PM, Koser ML, Carlson KR, Montefiori DC, Letvin NL, Papaneri AB, Pomerantz RJ, Dietzschold B, Silvera P, McGettigan JP, Schnell MJ.

J Infect Dis. 2007 Apr 1;195(7):980-8. Epub 2007 Feb 20.

PMID:
17330788
15.

Rabies virus glycoprotein as a carrier for anthrax protective antigen.

Smith ME, Koser M, Xiao S, Siler C, McGettigan JP, Calkins C, Pomerantz RJ, Dietzschold B, Schnell MJ.

Virology. 2006 Sep 30;353(2):344-56. Epub 2006 Jul 3.

16.

Enhanced humoral HIV-1-specific immune responses generated from recombinant rhabdoviral-based vaccine vectors co-expressing HIV-1 proteins and IL-2.

McGettigan JP, Koser ML, McKenna PM, Smith ME, Marvin JM, Eisenlohr LC, Dietzschold B, Schnell MJ.

Virology. 2006 Jan 20;344(2):363-77. Epub 2005 Oct 14.

17.

Strong cellular and humoral anti-HIV Env immune responses induced by a heterologous rhabdoviral prime-boost approach.

Tan GS, McKenna PM, Koser ML, McLinden R, Kim JH, McGettigan JP, Schnell MJ.

Virology. 2005 Jan 5;331(1):82-93.

18.

The effects of beta-aminopropionitrile on colonic anastomosis in rats.

Bulut T, Bilsel Y, Yanar H, Yamaner S, Balik E, Solakoglu S, Koser M.

J Invest Surg. 2004 Jul-Aug;17(4):211-9.

PMID:
15371163
19.

Rabies virus nucleoprotein as a carrier for foreign antigens.

Koser ML, McGettigan JP, Tan GS, Smith ME, Koprowski H, Dietzschold B, Schnell MJ.

Proc Natl Acad Sci U S A. 2004 Jun 22;101(25):9405-10. Epub 2004 Jun 14.

20.

[Gemcitabine/cisplatin vs. MVAC. 5 year survival outcome of the phase III study of chemotherapy of advanced urothelial carcinoma in Germany].

Lehmann J, Retz M, Steiner G, Albers P, Jaeger E, Knuth A, Lippert C, Koser M, Stockamp K, Otto C, Melchior H, Fassmann C, Potratz C, Loch T, Derigs HG, Becker T, Kälble T, Piechota HJ, Hertle L, Weinknecht S, Weissbach L, Al-Mwalad M, Hamza A, Henss H, Brkovic D, Pomer S, Roloff J, Walz P, Muschter R, Tunn U, Winter E, Bub P, Kaldenbach U, Roth S, Brauers A, Jakse G, Richter AE, Wirth M, Hartlapp J, Van Ahlen H, Stöckle M.

Urologe A. 2003 Aug;42(8):1074-86. Epub 2003 Apr 2. German.

PMID:
14513232
21.
22.

Serum prolidase I activity and some bone metabolic markers in patients with breast cancer: in relation to menopausal status.

Kir ZO, Oner P, Iyidoğan YO, Türkmen S, Koçak H, Koşer M, Küçücük SO.

Clin Biochem. 2003 Jun;36(4):289-94.

PMID:
12810158
23.

The association of vision-threatening ocular injury with infant walker use.

Koser M, DeRespinis PA.

Arch Pediatr Adolesc Med. 1995 Nov;149(11):1275-6. No abstract available.

PMID:
7581763
24.

Treatment of Pneumocystis carinii choroidopathy.

Koser MW, Jampol LM, MacDonell K.

Arch Ophthalmol. 1990 Sep;108(9):1214-5. No abstract available.

PMID:
2400340
25.

Percutaneous management of retroperitoneal abscesses.

Gordon DH, Macchia RJ, Glanz S, Koser MW, Laungani GB.

Urology. 1987 Oct;30(4):299-306.

PMID:
3310364
26.

Endourology: an overview of a new subspecialty.

Gordon DH, Macchia RJ, Koser MW, Glanz S, Laungani G.

N Y State J Med. 1986 Oct;86(10):522-7. Review. No abstract available.

PMID:
2946997
27.

Upper esophageal varices: report of three cases and review of the literature.

Glanz S, Koser MW, Dallemand S, Gordon DH.

Am J Gastroenterol. 1982 Mar;77(3):194-8.

PMID:
6979242
28.

Venography in axillary-subclavian vein thrombosis.

Martin EC, Koser M, Gordon DH.

Cardiovasc Radiol. 1979 Nov;2(4):261-6.

PMID:
391388
29.

The stimulus-secretion coupling of glucose-induced insulin release. Insulin release due to glycogenolysis in glucose-deprived islets.

Malaisse WJ, Sener A, Koser M, Ravazzola M, Malaisse-Lagae F.

Biochem J. 1977 May 15;164(2):447-54.

30.
31.

Identification of the alpha-stereospecific glucosensor in the pancreatic B-cell.

Malaisse WJ, Sener A, Koser M, Herchuelz A.

FEBS Lett. 1976 Jun 1;65(2):131-4. No abstract available.

32.

Letter: Do alpha-stereospecific glucoreceptors exist?

Malaisse WJ, Sener A, Koser M, Herchuelz A.

Lancet. 1976 Mar 6;1(7958):544. No abstract available.

PMID:
55820

Supplemental Content

Support Center